Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT05896852 for HIV-1-infection, Metabolic Syndrome is active, not recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One trial matched filter criteria
Card View
Back to Search
Georgetown UniversityHealthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV
Clinical Trial NCT05896852 is an interventional study for HIV-1-infection, Metabolic Syndrome that is active, not recruiting. It started on October 1, 2023 with plans to enroll 50 participants. Led by Georgetown University, it is expected to complete by October 1, 2026. The latest data from ClinicalTrials.gov was last updated on October 21, 2025.
Brief Summary
This study is being done to understand how a physical activity walking intervention affects metabolic parameters (i.e., blood sugar, cholesterol, certain body measurements) in people with and without HIV. This study involves a physical activity intervention where participants will progressively increase activity as tolerated over a six month period.
Detailed Description
This study is being done to understand how a physical activity walking intervention affects metabolic parameters (i.e., blood sugar, cholesterol, certain body measurements) in people with and without HIV. This study involves a physical activity intervention where participants will progressively increase the total number of daily steps to approximately 10,000 steps/day as tolerated. We will monitor participant steps and physical activity using a physical activity monitor. The study will consist of 5 in-person study visits where participants will complete body measurements, laboratory testing (for metabolic parameters e.g. blood sugar and cholesterol), and a questionnaire.
Official Title
Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV
Conditions
HIV-1-INFECTIONMetabolic SyndromeOther Study IDs
- STUDY00004962
NCT ID Number
Start Date (Actual)
2023-10-01
Last Update Posted
2025-10-21
Completion Date (Estimated)
2026-10
Enrollment (Estimated)
50
Study Type
Interventional
PHASE
N/A
Status
Active, not recruiting
Primary Purpose
Treatment
Design Allocation
N/A
Interventional Model
Single Group
Masking
None (Open Label)
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
ExperimentalIntervention Arm Participants will increase their physical activity over 6 months as tolerated, | Physical Activity Participants will increase their physical activity through walking. |
Primary Outcome Measures
Secondary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Acceptability of Study Activities (Recruitment) | To determine acceptability of study activities investigators will determine overall recruitment and determine percentage of the target recruitment that enrolled in the study at the 6 month study completion point (goal = 90% of our target). | 6 months |
Acceptability of Study Activities (Attrition) | Investigators will measure attrition by determination of the number of participants who complete all study visits (measured by total number of participants who complete the baseline, 3-month, and 6-month study visits - goal \>75%). These will be assessed at the end of the 6-month study period. | 6 months |
Adherence to Study Activities of Study Activities | Investigators will determine adherence to study activities by determination of the completion of study visits, completion of laboratory testing at study visits, and completion of step counting journals. Investigators will assess total number of documented study visits, completion of laboratory testing, and assessment of total number of days steps were entered in step logs. Investigators will assess the total number of visits, laboratory blood draws, and entries in to step log at each visit and determine overall percentage completed. | 6 months |
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Metabolic Parameters (Laboratory Measurement - blood glucose) | Laboratory measurements including fasting blood glucose (mg/dL) will be at baseline, 3-month, and 6-month visits. Change (increase/decrease) in the fasting blood glucose measurement will be assessed. | 6 months |
Metabolic Parameters (Laboratory Measurement - lipids) | Laboratory measurements including lipids (mg/dL) will be at baseline, 3-month, and 6-month visits. Change (increase/decrease) in the lipid measurements will be assessed. | 6 months |
Metabolic Parameters (Laboratory Measurement - HBA1c) | Laboratory measurements including HBA1c (mmol/mol) will be measured at baseline, 3-month, and 6-month visits. Change (increase/decrease) in the HBA1c measurement will be assessed. | 6 months |
Body Composition (Waist Circumference [cm]) | Body measurement including waist circumference in centimeters will be assessed at baseline, 3-month, and 6-month follow-up visits. Changes (increase/decrease) waist circumference will be assessed. | 6 months |
Body Composition (BMI [kg/m^2]) | Body measurement including BMI \[kg/m\^2\] will be assessed at baseline, 3-month, and 6-month follow-up visits. Changes (increase/decrease) BMI will be assessed. | 6 months |
Quality of Life (Health-Related Quality of Life (SF-36)) | Health related quality of life will be assessed using the Health-Related Quality of Life (SF-36) scale. The scale includes eight measures - physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health. Scores range from 0 (worst) to 100 (best). Changes will be assessed from baseline to responses at the 6 month follow-up. | 6 months |
Eligibility Criteria
Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
Accepts Healthy Volunteers
Yes
- Age ≥ 18
- Persons living with or without HIV
- Metabolic Syndrome or risk factors for metabolic syndrome with BMI >=30
- Able to provide informed consent
- No physical limitations that prevent walking for more than 10 minutes
- Can provide evidence of medical clearance by healthcare provider, if required before or during the study
- Currently exercising regularly (at least 2x weekly of at least 20minutes of moderate or vigorous activity)
- Current enrollment in another physician activity and/or dietary clinical trial or on diet/weight-loss program
- Active plans for bariatric surgery
- Inability to commit to the intervention schedule
- Not eligible as per screening form
- Currently pregnant or planning to become pregnant
Georgetown University75 active trials to exploreNo contact data.
1 Study Locations in 1 Countries
District of Columbia
Georgetown University, Washington D.C., District of Columbia, 20007, United States